RecruitingNCT03039309

Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom

Endoscopic Submucosal Dissection in the Treatment of Early Gastrointestinal Neoplasia: A UK Cohort Study to Assess Effectiveness and Safety

Sponsor

Portsmouth Hospitals NHS Trust

Enrollment

500 participants

Start Date

Aug 5, 2016

Study Type

OBSERVATIONAL

Conditions

Endoscopic Submucosal Dissection

Summary

Multicentre cohort study on the use of endoscopic submucosal dissection for the treatment of early gastrointestinal neoplasia.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This registry tracks patients in the United Kingdom who undergo endoscopic submucosal dissection (ESD) — a minimally invasive endoscopic technique used to remove early-stage gastrointestinal cancers and pre-cancerous lesions from the stomach, colon, or esophagus. The goal is to collect data on outcomes and complications to improve future ESD practice. You may be eligible if: - You are 18 years of age or older (male or female) - You are undergoing endoscopic submucosal dissection for an early GI neoplasm (pre-cancer or early cancer) - You are able to give informed consent You may NOT be eligible if: - You are under 18 years of age - You are unable to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEndoscopic Submucosal Dissection

Endoscopic submucosal dissection is an endoscopic resection technique that utilises an endoscopic knife to remove lesions within the gastrointestinal tract in an en bloc fashion.